Results 271 to 280 of about 306,022 (339)

Work Complexity and Musculoskeletal Symptoms in Healthcare Workers. [PDF]

Healthcare (Basel)
Vieira EMA, Silva JMND, Leite WKDS, Araújo GL.   +3 more
europepmc   +1 more source

Medical Care Output and Productivity [PDF]

Frank R. Lichtenberg
core  

Atypical Visually Guided Precision Grip Control in Middle‐Aged and Older Autistic Adults

Autism Research, EarlyView.
ABSTRACT Sensorimotor impairments are well documented in autism spectrum disorder (ASD). However, little is known about how these difficulties present in middle‐aged and older autistic adults or how they relate to demographic factors and autistic traits.
Zheng Wang, Hang Qu, Danielle Christensen, Hanna M. Gemmell, Ellen M. Parks, Kyla E. Wetherington, Ann‐Marie Orlando, Regilda A. Romero, Bikram Karmakar, David E. Vaillancourt   +9 more
wiley   +1 more source

Feasibility and utility of telemedical support through a paramedic-led primary response service to aid emergency services in northwestern Germany. [PDF]

BMC Health Serv Res
Overheu D, Schäfer ST, Rosner B, Warnecke T, Jacobsen N.   +4 more
europepmc   +1 more source

The study of marketing opportunities for the use of the raw material of feverfew (Tanacetum parthenium L.) in the pharmacotherapy of musculoskeletal system diseases

О.М. Yevtushenko, О. А. Рубан, Mariia Velia, І. V. Kovalevska   +3 more
openalex   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon, Sophie Delhomme, Delphine Launay, Séverine Blesson, Stéphanie Braillard, Pegah Maghdooni, Frauke Assmus, Richard Hoglund, Joel Tarning, Sabrina Loyau, Byron Arana, Mathilde Latreille‐Barbier, Yves Donazzolo   +12 more
wiley   +1 more source

Enhancing the Care of Patients With Bone and Joint Infections Through Educational Interventions. [PDF]

Open Forum Infect Dis
Shah NB, Seidelman J, Belden K, Thottacherry E, Lastinger A, Nori P, Beaulieu RM, Tai DBG.   +7 more
europepmc   +1 more source